Welcome to Prism!

Upload scholarly work, create communities, get citable links and more. To get the most out of Prism, log in with your NetID and check out our guide.

Published 2005 | Version v1.0.0
Journal Article Open

Treatment-Continuity of ADHD Compared Using Immediate-Release and Extended-Release MPH

Abstract

The continuity of methylphenidate (MPH) therapy for ADHD in young Medicaid beneficiaries (ages 6 to 17 years) treated with immediate-release (IR) or extended-release (ER) MPH formulations was compared in an analysis of statewide California Medicaid claims (2000-2003) conducted at Columbia University, New York; University of Pennsylvania, Philadelphia; and McNeil Pharmaceuticals, Fort Washington, PA.

Files

PNB-19-52.pdf
Files (1.4 MB)
Name Size Download all
md5:05cf9a84efe12595573c203feee29362
1.4 MB Preview Download

Additional details

Created:
March 30, 2023
Modified:
March 30, 2023